Editorial Ahead of print
PubMed: 42684572 DOI: 10.1007/s40264-026-01723-0
ISoP MENA Chapter: Strategic Development and Future Directions Following a Decade of Strengthening Pharmacovigilance in the Middle East and North Africa.
Drug Saf
Authors: Hadir Rostom, Mohamed A Elhawary, Mayada Alkhakany, Manal M Younus, Thamir Alshammari, Felipe Villalobos, Omar Aimer
Affiliations
- ISoP MENA Chapter Founding Group, Cairo, Egypt.
- Faculty of Pharmacy, MSA University, 6th of October City, Giza, Egypt.
- International Society of Pharmacovigilance, ISoP Secretariat Ltd, London, UK.
- ISoP MENA Chapter Founding Group, Cairo, Egypt. Medical Affairs, SAJA Pharmaceuticals Co. Ltd, Jeddah, Saudi Arabia.
- ISoP MENA Chapter Founding Group, Cairo, Egypt. Seven D Consultancy, Dubai, UAE.
- Iraqi Pharmacovigilance Centre, Ministry of Health, Baghdad, Iraq.
- Department of Pharmacy Practice, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
- Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
- Fundació Institut Universitari per a la Recerca a l'Atenció Primà ria de Salut Jordi Gol i Gurina (IDIAPJGol), Gran Via Corts Catalanes, 587 à tic. 08007, Barcelona, Spain. International Society of Pharmacovigilance, ISoP Secretariat Ltd, London, UK.
- International Society of Pharmacovigilance, ISoP Secretariat Ltd, London, UK. InnoVigilance, Laval, QC, Canada.
MeSH
Drug-Related Side Effects And Adverse Reactions, Toxicology, Pharmacovigilance